Bausch Health Cos Debt Issuance/Retirement Net - Total 2010-2024 | BHC
Bausch Health Cos debt issuance/retirement net - total from 2010 to 2024. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
Bausch Health Cos Annual Debt Issuance/Retirement Net - Total
(Millions of US $) |
| 2024 |
$-799 |
| 2023 |
$1,581 |
| 2022 |
$-1,010 |
| 2021 |
$-1,340 |
| 2020 |
$-2,187 |
| 2019 |
$1,554 |
| 2018 |
$-1,160 |
| 2017 |
$-4,786 |
| 2016 |
$-1,216 |
| 2015 |
$12,639 |
| 2014 |
$-2,267 |
| 2013 |
$2,012 |
| 2012 |
$3,475 |
| 2011 |
$2,771 |
| 2010 |
$201 |
| 2009 |
$350 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.638B |
$9.625B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
